Predictive Oncology Inc (POAI)

[77Port]

Here is a serious deep dive into POAI by a science writer in Seeking Alpha, hands down, the best article I've ever read about this company and well worth the read.

The intro: "Here, we highlight Predictive Oncology, a microcap biopharma AI company focused on oncology, with unique assets that differentiate it from other oncology AI companies. We believe the company could be undervalued, as it has valuable assets that we believe nobody else in the world has."

And:

"PDCLs collectively owned by Predictive Oncology (through Helomics, can be “3D cultured” by TumorGenesis) may have massive value. When comparing to other AI drug discovery platforms, what better represents patients’ tumors: an intricate AI algorithm or real patient samples? Predictive Oncology’s tumor knowledgebase, “TumorSpace,” includes:

- 150,000 patient cases
- 131 tumor types
- 338 tumor subtypes
- 643 anatomic sites
- Clinical and demographic information
- Biomarker and mutational profiles
- Access to 10+ years of historical clinical outcome data"

Link:
https://seekingalpha.com/article/4408638-predictive-oncology-potentially-undervalued-drug-discovery-ai-company